As of April 2026, BPC-157 is not explicitly listed on the World Anti-Doping Agency (WADA) Prohibited List by name, though WADA's catch-all S0 category (non-approved substances) captures any compound without regulatory approval for human therapeutic use
Oxidative Stress and Neuroprotection Sviridov, I
Conclusion: An Honest Assessment of Where the Evidence Stands BPC-157 is not a miracle compound, and it is not a fringe curiosity
ILS said the sample was prepared with nuclease-free water, but the exact dilution ratio and the instructions for those particular strips remain unknown
Gastrointestinal Tissue Research BPC-157 is derived from a gastric protein fragment and is investigated in preclinical GI models for how it may influence mucosal signaling, inflammatory pathway modulation, and cellular proliferation
Its core pathological feature is excessive accumulation of adipose tissue, accompanied by abnormal proliferation, differentiation, and metabolic dysfunction of adipocytes, which in turn induce a series of complications including insulin resistance, nonalcoholic fatty liver disease, and cardiovascular diseases